Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$68.12
0.901.34%
At close: -
$68.12
0.000.00%
After Hours: May 16, 6:54 PM EDT
Comments
Loading...
Insmed Analyst Ratings and Price Targets | NASDAQ:INSM | Benzinga
Insmed Inc has a consensus price target of $85.25 based on the ratings of 22 analysts. The high is $109 issued by UBS on May 9, 2025. The low is $42 issued by Wolfe Research on February 15, 2024. The 3 most-recent analyst ratings were released by Jefferies, UBS, and HC Wainwright & Co. on May 13, 2025, May 9, 2025, and April 22, 2025, respectively. With an average price target of $101.33 between Jefferies, UBS, and HC Wainwright & Co., there's an implied 48.76% upside for Insmed Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Jefferies
UBS
HC Wainwright & Co.
B of A Securities
RBC Capital
1calculated from analyst ratings
Analyst Ratings for Insmed
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/13/2025 | Buy Now | 54.14% | Jefferies | Kelly Shi38% | → $105 | Initiates | → Buy | Get Alert |
| 05/09/2025 | Buy Now | 60.01% | UBS | Trung Huynh64% | $110 → $109 | Maintains | Buy | Get Alert |
| 04/22/2025 | Buy Now | 32.12% | HC Wainwright & Co. | Andrew Fein55% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 03/20/2025 | Buy Now | 40.93% | B of A Securities | Jason Zemansky68% | $92 → $96 | Maintains | Buy | Get Alert |
| 03/19/2025 | Buy Now | 46.8% | RBC Capital | Leonid Timashev37% | $100 → $100 | Reiterates | Outperform → Outperform | Get Alert |
| 03/06/2025 | Buy Now | 61.48% | UBS | Trung Huynh64% | $105 → $110 | Maintains | Buy | Get Alert |
| 02/25/2025 | Buy Now | 46.8% | RBC Capital | Leonid Timashev37% | → $100 | Initiates | → Outperform | Get Alert |
| 02/25/2025 | Buy Now | 48.27% | Guggenheim | Vamil Divan73% | $101 → $101 | Reiterates | Buy → Buy | Get Alert |
| 02/24/2025 | Buy Now | 32.12% | HC Wainwright & Co. | Andrew Fein55% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 02/21/2025 | Buy Now | 58.54% | Truist Securities | Nicole Germino39% | $105 → $108 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | 40.93% | Stifel | Stephen Willey48% | $97 → $96 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | 32.12% | HC Wainwright & Co. | Andrew Fein55% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 02/20/2025 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim44% | — | Reiterates | Overweight → Overweight | Get Alert |
| 02/19/2025 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim44% | — | Reiterates | Overweight → Overweight | Get Alert |
| 02/19/2025 | Buy Now | 57.08% | Wells Fargo | Tiago Fauth42% | $85 → $107 | Maintains | Overweight | Get Alert |
| 02/11/2025 | Buy Now | 42.4% | Stifel | Stephen Willey48% | $88 → $97 | Maintains | Buy | Get Alert |
| 02/07/2025 | Buy Now | 35.06% | JP Morgan | Jessica Fye62% | $83 → $92 | Maintains | Overweight | Get Alert |
| 02/07/2025 | Buy Now | 48.27% | Guggenheim | Vamil Divan73% | $95 → $101 | Maintains | Buy | Get Alert |
| 02/06/2025 | Buy Now | 32.12% | Morgan Stanley | Matthew Harrison59% | $85 → $90 | Maintains | Overweight | Get Alert |
| 11/22/2024 | Buy Now | 21.84% | JP Morgan | Jessica Fye62% | $74 → $83 | Maintains | Overweight | Get Alert |
| 11/01/2024 | Buy Now | 54.14% | Truist Securities | Nicole Germino39% | $100 → $105 | Reiterates | Buy → Buy | Get Alert |
| 11/01/2024 | Buy Now | 32.12% | HC Wainwright & Co. | Andrew Fein55% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 10/11/2024 | Buy Now | 46.8% | Truist Securities | Nicole Germino39% | $85 → $100 | Maintains | Buy | Get Alert |
| 10/09/2024 | Buy Now | 26.25% | B of A Securities | Jason Zemansky68% | $84 → $86 | Maintains | Buy | Get Alert |
| 10/03/2024 | Buy Now | 8.63% | JP Morgan | Jessica Fye62% | $72 → $74 | Maintains | Overweight | Get Alert |
| 09/09/2024 | Buy Now | — | Cantor Fitzgerald | Josh Schimmer50% | — | Reiterates | → Overweight | Get Alert |
| 08/29/2024 | Buy Now | 32.12% | HC Wainwright & Co. | Andrew Fein55% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 08/12/2024 | Buy Now | 24.78% | Truist Securities | Nicole Germino39% | $88 → $85 | Maintains | Buy | Get Alert |
| 08/12/2024 | Buy Now | 32.12% | HC Wainwright & Co. | Andrew Fein55% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2024 | Buy Now | 43.86% | TD Cowen | Ritu Baral34% | $75 → $98 | Maintains | Buy | Get Alert |
| 08/09/2024 | Buy Now | 23.31% | UBS | Trung Huynh64% | $78 → $84 | Maintains | Buy | Get Alert |
| 08/09/2024 | Buy Now | 29.18% | Stifel | Stephen Willey48% | $74 → $88 | Maintains | Buy | Get Alert |
| 07/12/2024 | Buy Now | 24.78% | Morgan Stanley | Matthew Harrison59% | $60 → $85 | Maintains | Overweight | Get Alert |
| 07/10/2024 | Buy Now | 49.74% | Goldman Sachs | Andrea Tan37% | $74 → $102 | Maintains | Buy | Get Alert |
| 07/09/2024 | Buy Now | 39.46% | Guggenheim | Vamil Divan73% | $70 → $95 | Maintains | Buy | Get Alert |
| 07/08/2024 | Buy Now | 32.12% | HC Wainwright & Co. | Andrew Fein55% | $70 → $90 | Maintains | Buy | Get Alert |
| 07/05/2024 | Buy Now | 21.84% | B of A Securities | Jason Zemansky68% | $83 → $83 | Maintains | Buy | Get Alert |
| 07/02/2024 | Buy Now | 2.76% | HC Wainwright & Co. | Andrew Fein55% | $70 → $70 | Reiterates | Buy → Buy | Get Alert |
| 07/01/2024 | Buy Now | 29.18% | Truist Securities | Nicole Germino39% | $68 → $88 | Maintains | Buy | Get Alert |
| 06/28/2024 | Buy Now | 21.84% | B of A Securities | Jason Zemansky68% | $62 → $83 | Maintains | Buy | Get Alert |
| 06/21/2024 | Buy Now | 10.1% | Evercore ISI Group | Josh Schimmer50% | $42 → $75 | Maintains | Outperform | Get Alert |
| 06/20/2024 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim44% | — | Reiterates | → Overweight | Get Alert |
| 06/20/2024 | Buy Now | 5.7% | JP Morgan | Jessica Fye62% | $55 → $72 | Maintains | Overweight | Get Alert |
| 06/07/2024 | Buy Now | 20.38% | Mizuho | Graig Suvannavejh49% | $36 → $82 | Maintains | Buy | Get Alert |
| 06/05/2024 | Buy Now | 8.63% | Stifel | Stephen Willey48% | $67 → $74 | Maintains | Buy | Get Alert |
| 05/31/2024 | Buy Now | -1.64% | Stifel | Stephen Willey48% | $39 → $67 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | -1.64% | TD Cowen | Ritu Baral34% | $45 → $67 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | -14.86% | UBS | Trung Huynh64% | $46 → $58 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | 8.63% | Goldman Sachs | Andrea Tan37% | $49 → $74 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | 13.04% | Wells Fargo | Tiago Fauth42% | $55 → $77 | Maintains | Overweight | Get Alert |
| 05/29/2024 | Buy Now | -0.18% | Truist Securities | Nicole Germino39% | $48 → $68 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | -7.52% | Barclays | Leon Wang64% | $40 → $63 | Maintains | Overweight | Get Alert |
| 05/29/2024 | Buy Now | -19.26% | JP Morgan | Jessica Fye62% | $36 → $55 | Maintains | Overweight | Get Alert |
| 05/29/2024 | Buy Now | -8.98% | B of A Securities | Jason Zemansky68% | $40 → $62 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | 2.76% | HC Wainwright & Co. | Andrew Fein55% | $52 → $70 | Maintains | Buy | Get Alert |
| 05/28/2024 | Buy Now | -11.92% | Morgan Stanley | Matthew Harrison59% | $43 → $60 | Maintains | Overweight | Get Alert |
| 05/28/2024 | Buy Now | -41.28% | B of A Securities | Jason Zemansky68% | $40 → $40 | Maintains | Buy | Get Alert |
| 05/16/2024 | Buy Now | -29.54% | Truist Securities | Nicole Germino39% | $48 → $48 | Maintains | Buy | Get Alert |
| 05/15/2024 | Buy Now | -28.07% | Goldman Sachs | Andrea Tan37% | $40 → $49 | Maintains | Buy | Get Alert |
| 05/14/2024 | Buy Now | -23.66% | HC Wainwright & Co. | Andrew Fein55% | $52 → $52 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | Buy Now | -47.15% | Mizuho | Graig Suvannavejh49% | $35 → $36 | Maintains | Buy | Get Alert |
| 05/10/2024 | Buy Now | -36.88% | Morgan Stanley | Matthew Harrison59% | $40 → $43 | Maintains | Overweight | Get Alert |
| 04/23/2024 | Buy Now | -29.54% | Truist Securities | Nicole Germino39% | → $48 | Initiates | → Buy | Get Alert |
| 04/11/2024 | Buy Now | -41.28% | Barclays | Leon Wang64% | $37 → $40 | Maintains | Overweight | Get Alert |
| 04/01/2024 | Buy Now | -19.26% | Wells Fargo | Tiago Fauth42% | $55 → $55 | Maintains | Overweight | Get Alert |
| 02/27/2024 | Buy Now | -20.73% | Guggenheim | Vamil Divan73% | $52 → $54 | Maintains | Buy | Get Alert |
| 02/27/2024 | Buy Now | -32.47% | UBS | Trung Huynh64% | → $46 | Initiates | → Buy | Get Alert |
| 02/23/2024 | Buy Now | -41.28% | B of A Securities | Jason Zemansky68% | $37 → $40 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | -38.34% | Wolfe Research | Andy Chen37% | → $42 | Initiates | → Outperform | Get Alert |
| 11/20/2023 | Buy Now | -47.15% | JP Morgan | Jessica Fye62% | → $36 | Reinstates | → Overweight | Get Alert |
| 10/27/2023 | Buy Now | -48.62% | Mizuho | Graig Suvannavejh49% | $33 → $35 | Maintains | Buy | Get Alert |
| 09/21/2023 | Buy Now | -20.73% | Cantor Fitzgerald | Jennifer Kim44% | $46 → $54 | Maintains | Overweight | Get Alert |
| 09/19/2023 | Buy Now | -32.47% | Cantor Fitzgerald | Jennifer Kim44% | → $46 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | Buy Now | -38.34% | Evercore ISI Group | Josh Schimmer50% | $32 → $42 | Maintains | Outperform | Get Alert |
| 09/06/2023 | Buy Now | -51.56% | Mizuho | Graig Suvannavejh49% | $30 → $33 | Maintains | Buy | Get Alert |
| 09/06/2023 | Buy Now | -45.68% | B of A Securities | Jason Zemansky68% | $35 → $37 | Maintains | Buy | Get Alert |
| 09/06/2023 | Buy Now | -23.66% | HC Wainwright & Co. | Andrew Fein55% | → $52 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2023 | Buy Now | -23.66% | Guggenheim | Vamil Divan73% | $50 → $52 | Reiterates | Buy → Buy | Get Alert |
| 08/04/2023 | Buy Now | -48.62% | Stifel | Stephen Willey48% | $33 → $35 | Maintains | Buy | Get Alert |
| 08/04/2023 | Buy Now | -39.81% | Morgan Stanley | Matthew Harrison59% | $41 → $41 | Reiterates | Overweight → Overweight | Get Alert |
| 08/04/2023 | Buy Now | -23.66% | HC Wainwright & Co. | Andrew Fein55% | → $52 | Reiterates | Buy → Buy | Get Alert |
| 07/26/2023 | Buy Now | -55.96% | Mizuho | Graig Suvannavejh49% | $28 → $30 | Maintains | Buy | Get Alert |
| 07/26/2023 | Buy Now | -26.6% | Guggenheim | Vamil Divan73% | → $50 | Initiates | → Buy | Get Alert |
| 05/09/2023 | Buy Now | -23.66% | HC Wainwright & Co. | Andrew Fein55% | → $52 | Reiterates | → Buy | Get Alert |
| 02/24/2023 | Buy Now | -32.47% | Cantor Fitzgerald | Jennifer Kim44% | $49 → $46 | Maintains | Overweight | Get Alert |
| 02/24/2023 | Buy Now | -32.47% | Credit Suisse | Judah Frommer65% | → $46 | Reiterates | → Outperform | Get Alert |
| 02/24/2023 | Buy Now | -23.66% | HC Wainwright & Co. | Andrew Fein55% | → $52 | Reiterates | → Buy | Get Alert |
| 01/20/2023 | Buy Now | -48.62% | Barclays | Leon Wang64% | $37 → $35 | Maintains | Overweight | Get Alert |
| 01/09/2023 | Buy Now | -42.75% | Goldman Sachs | Andrea Tan37% | $44 → $39 | Maintains | Buy | Get Alert |
| 12/09/2022 | Buy Now | -58.9% | Mizuho | Graig Suvannavejh49% | → $28 | Initiates | → Buy | Get Alert |
| 12/08/2022 | Buy Now | -45.68% | Barclays | Leon Wang64% | → $37 | Initiates | → Overweight | Get Alert |
| 12/07/2022 | Buy Now | -45.68% | Barclays | Leon Wang64% | → $37 | Initiates | → Overweight | Get Alert |
| 11/18/2022 | Buy Now | -42.75% | B of A Securities | Jason Zemansky68% | → $39 | Initiates | → Buy | Get Alert |
| 10/27/2022 | Buy Now | -26.6% | SVB Leerink | Joseph Schwartz64% | $52 → $50 | Maintains | Outperform | Get Alert |
| 10/25/2022 | Buy Now | -28.07% | Cantor Fitzgerald | Jennifer Kim44% | $53 → $49 | Maintains | Overweight | Get Alert |
| 10/21/2022 | Buy Now | -22.2% | Cowen & Co. | Ritu Baral34% | $56 → $53 | Maintains | Outperform | Get Alert |
| 07/15/2022 | Buy Now | -39.81% | Morgan Stanley | Matthew Harrison59% | $46 → $41 | Maintains | Overweight | Get Alert |
| 05/24/2022 | Buy Now | -29.54% | Goldman Sachs | Andrea Tan37% | $56 → $48 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Insmed (INSM) stock?
The latest price target for Insmed (NASDAQ:INSM) was reported by Jefferies on May 13, 2025. The analyst firm set a price target for $105.00 expecting INSM to rise to within 12 months (a possible 54.14% upside). 57 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Insmed (INSM)?
The latest analyst rating for Insmed (NASDAQ:INSM) was provided by Jefferies, and Insmed initiated their buy rating.
When was the last upgrade for Insmed (INSM)?
There is no last upgrade for Insmed
When was the last downgrade for Insmed (INSM)?
There is no last downgrade for Insmed.
When is the next analyst rating going to be posted or updated for Insmed (INSM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Insmed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Insmed was filed on May 13, 2025 so you should expect the next rating to be made available sometime around May 13, 2026.
Is the Analyst Rating Insmed (INSM) correct?
While ratings are subjective and will change, the latest Insmed (INSM) rating was a initiated with a price target of $0.00 to $105.00. The current price Insmed (INSM) is trading at is $68.12, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
